Skip to content
Announcement:

The results of a recent collaboration between Sanofi, GSK, Lilly, Vesalius Therapeutics, Leiden University, Heidelberg University, ElmorePathology and Newcells aimed at enhancing safety assessments has just been published. Find out how rat kidney gene co-expression networks has enabled biomarker identification and human translation for renal safety assessments.

WHAT WE DO

Learning from structures in the body, we recreate functional 3D in vitro models through innovation and science. Our models incorporate the “best biology” and are predictive of new drugs’ in vivo safety and efficacy.

Don't miss out on our latest innovations: follow us on Linkedin

Author

Newcells Biotech

Published

24th April, 2019

Categories

Update

Get our latest updates straight to your inbox

Book a Call